OncoTAb Competitors and Similar CompaniesClear all

OncoTAb's competitors and similar companies include GestVision, Arbor Vita, GyneConcepts and nVision Medical.
OncoTAb
OncoTAb
OncoTAb is a biotechnology company engaged in cancer care by addressing unmet cancer diagnostic and therapeutic needs.
GestVision
GestVision
GestVision is a biotechnology company developing a test to help diagnose preeclampsia.
Arbor Vita
Arbor Vita
Arbor Vita Corporation (AVC) is a biotech company developing cancer diagnostics.
GyneConcepts
GyneConcepts
GyneConcepts (previously known as GyneTech) is a company focused on the development of a medical device for early detection of cervical cancer.
nVision Medical
nVision Medical
nVision is a medical device company developing a tool to screen women for ovarian cancer.
Founding Date
Founding Date
2011
Founding Date
2014
Founding Date
1998
Founding Date
1994
Founding Date
2011
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Charlotte, US HQ
Locations
Groton, US HQ
Locations
Fremont, US HQ
Locations
Atlanta, US HQ
Locations
San Bruno, US HQ
Employees
Employees
3
Employees
233% decrease
Employees
24
Employees
3
Employees
6

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 100k
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16.4m
For sources of this data, please see the company profile

View Company Profiles

GestVision
HQ
Groton, US
Employees
2↓ 33% decrease

GestVision is a biotechnology company developing a test to help diagnose preeclampsia.

View company
Arbor Vita
HQ
Fremont, US
Employees
24

Arbor Vita Corporation (AVC) is a biotech company developing cancer diagnostics.

View company
GyneConcepts
HQ
Atlanta, US
Employees
3

GyneConcepts (previously known as GyneTech) is a company focused on the development of a medical device for early detection of cervical cancer.

View company
nVision Medical
HQ
San Bruno, US

nVision is a medical device company developing a tool to screen women for ovarian cancer.

View company